Anti-OTULIN antibody
5
(3 Reviews)
|
(12 Publications)
Rabbit Polyclonal OTULIN antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 12 publications. Immunogen corresponding to Recombinant Fragment Protein within Human OTULIN aa 50-200.
View Alternative Names
FAM105B, OTULIN, Ubiquitin thioesterase otulin, Deubiquitinating enzyme otulin, OTU domain-containing deubiquitinase with linear linkage specificity, Ubiquitin thioesterase Gumby
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-OTULIN antibody (AB151117)
Immunohistochemical analysis of paraffin-embedded Human kidney tissue labeling FAM105B with ab151117 at 1/50 dilution.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-OTULIN antibody (AB151117)
Immunofluorescent staining of Human cell line U-2 OS shows positivity in plasma membrane and mitochondria. Recommended concentration of ab151117 1-4 µg/ml. Cells treated with PFA/Triton X-100.
- WB
Unknown
Western blot - Anti-OTULIN antibody (AB151117)
All lanes:
Western blot - Anti-OTULIN antibody (ab151117) at 1/100 dilution
Lane 1:
RT 4 cell lysate
Lane 2:
U 251 MG cell lysate
Lane 3:
Human plasma lysate
Lane 4:
Human liver tissue lysate
Lane 5:
Human tonsil tissue lysate
Predicted band size: 40 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
OTULIN regulates inflammation and immune signaling. It often functions as a part of the LUBAC (linear ubiquitin chain assembly complex) ensuring homeostasis by preventing excessive activation of immune responses. OTULIN’s activity modulates NF-kB signaling an important pathway for immune and inflammatory responses. The enzyme maintains this balance to prevent unwanted inflammation promoting cellular health.
Pathways
OTULIN influences both the NF-kB pathway and the Wnt signaling pathway. In the NF-kB pathway it interacts closely with proteins such as NEMO (NF-kB essential modulator) and inhibits prolonged activation by removing linear ubiquitin chains. Likewise in the Wnt pathway OTULIN's role involves the regulation of signaling having indirect effects on cell proliferation and differentiation processes. Its ability to modulate these pathways highlights its integral role in maintaining immune function and development.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Journal of experimental & clinical cancer research : CR 43:330 PubMed39721999
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:5515 PubMed38951495
2024
Applications
Unspecified application
Species
Unspecified reactive species
EMBO molecular medicine 14:e14901 PubMed35170849
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 37:109777 PubMed34610306
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:5416 PubMed34518544
2021
Applications
Unspecified application
Species
Unspecified reactive species
BMC oral health 21:290 PubMed34092220
2021
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 39:e103303 PubMed33215740
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 29:3652-3663.e5 PubMed31825842
2019
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 36:1147-1166 PubMed28258062
2017
Applications
WB
Species
Human
Cell reports 16:2271-80 PubMed27545878
2016
Applications
WB
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com